APOE, Estrogen, and the Spark We Can’t Afford to Lose

🧬 What do a Nobel Prize–worthy gene, a hormone still fighting for its reputation, and a Realtor building an Alzheimer’s app in New Hampshire have in common?

A spark.

When Dr. Christin Glorioso shared her own APOEε4 status—and the lifestyle choices that may override its risk—it reminded me why MiM exists in the first place.

So just to be clear: this isn’t a rabbit hole. This is the path.

Because MiM was built for exactly this moment. For people who are still early, still living, still trying to hold on to structure and dignity while the system tells them to just... wait.

This post—about risk, about early support, about agency—fits our mission completely. It’s what we’ve been saying all along:

🧠 MiM isn’t here for the end of the story. It’s here for the middle—the part no one else seems to be helping with.

It’s not just about diagnosis. It’s about identity.
Not just prevention. Purpose.
And not just waiting for the system to catch up, but creating the kind of support now that too many people still can’t find.

👉 Read Dr. Glorioso’s full post here

And then let’s talk about why this matters for every woman, every family, and every person terrified of the slow fade they’re told to just prepare for.